Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
Condition:   SmallpoxInterventions:   Biological: ACAM1000;   Biological: vaccinia virus (calf lymph) smallpox vaccine: DryvaxSponsors:   Sanofi;   Sanofi Pasteur, a Sanofi CompanyTerminated - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2003 Category: Research Source Type: clinical trials